A recent study has demonstrated that the inhibition of FOXA2 induced by TGF-β, along with the activation of TEAD2/4, facilitates the reprogramming of a set of enhancers pre-existing within TADs, further activating the EMT process and promoting cancer cell metastasis [100]. Here, TGFB1 is linked to cancer.